The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 14)
Benzinga · 2d ago
Bio-Techne Announces Launch of Professional Assay Services - Dedicated Source for RNA in situ Hybridization Assays in Spatial Gene Expression Analysis
Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD), a Bio-Techne brand, completed an extensive rebranding effort in response to increased demand for its Assay Services offered at its Newark, CA laboratory. At the hea...
PR Newswire · 2d ago
Uptrend Call Working As Bio-Techne Corp Stock Rises 9.4% (TECH)
Apr 14, 2021 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Bio-Techne Corp (NASDAQ:TECH) on March 12th, 2021 at $379.61. In... · 2d ago
The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 13)
Benzinga · 3d ago
BRIEF-Bio-Techne Announces Licensing Of Proprietary Antibody To Xencor For Therapeutic Development · 3d ago
Bio-Techne Announces Licensing of Proprietary Antibody to Xencor for Therapeutic Development
, /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced a license agreement for use of a proprietary Bio-Techne antibody by Xencor, Inc., a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines ...
PR Newswire - PRF · 3d ago
Immunoprecipitation Kit Market Trends Detailed Analysis of Current Industry Figures with Forecasts Growth By 2026
Apr 13, 2021 (Market Insight Reports) -- According to business intelligence report on Immunoprecipitation Kit market, Covid-19 pandemic will have lasting...
Market Insight Reports · 3d ago
Global COVID-19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay Medical Device Pipeline Assessment 2020-2021: Pipeline Products Ranging from Early Development to Approved / Issued Stage
Dublin, April 13, Apr 13, 2021 (GLOBE NEWSWIRE via COMTEX) -- Dublin, April 13, 2021 (GLOBE NEWSWIRE) -- The "COVID-19 Enzyme Immuno Assay/Enzyme Linked...
GlobeNewswire · 4d ago
Gobal PCR Technologies Market By Type, By Application, By Segmentation, By Region, and By Country
Apr 12, 2021 (Heraldkeepers) -- Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive...
Heraldkeepers · 5d ago
CpG Oligodeoxynucleotide Market Growth Rate, Overview, Price Analysis of Top Manufactures Profiles and Forecast 2027
Apr 10, 2021 (Market Insight Reports) -- CpG oligodeoxynucleotide (CpG ODN), a synthetic oligodeoxynucleotide, contains unmethylated CpG motifs that are...
Market Insight Reports · 04/10 10:51
Gel Imaging Documentation Market : New Opportunities, Top Trends, Rising Demand, Emerging Growth, Business Development and Regional Analysis 2028 | Impact of COVID-19 Pandemic
Apr 09, 2021 (AmericaNewsHour) -- Research Nester published a report titled "Gel Imaging Documentation Market: Global Demand Analysis & Opportunity...
AmericaNewsHour · 04/09 13:33
qPCR and dPCR Instrumentation Market Size is Expected to Grow at a CAGR of 7.3 Globally with Top Countries Data Analysis and Forecast 2021–2026
Apr 08, 2021 (The Expresswire) -- Global "qPCR and dPCR Instrumentation Market"(2021-2026) status and position of worldwide and key regions, with...
The Express Wire · 04/09 03:55
QGEN vs. TECH: Which Stock Should Value Investors Buy Now? · 04/09 01:59
How to Identify the Opportunity and Potential Pitfalls in Bio-techne Corp Common Stock $TECH
Apr 08, 2021 (Stock Traders Daily via COMTEX) -- This Bio-techne Corp Common Stock (NASDAQ: TECH) report helps investors and traders identify both...
Stock Traders Daily · 04/08 21:23
Bio-Techne Announces Commercial Release Of Abby Automated Western System For Simple Western And Introduces Stellar Modules For Jess
 Bio-Techne Corporation (NASDAQ:TECH) today announced that ProteinSimple, a Bio-Techne brand, released Abby, its next generation chemiluminescence system that automates traditional Western blotting.  This
Benzinga · 04/08 11:02
Bio-Techne seals Asuragen acquisition
Bio-Techne Corporation (TECH) has completed the acquisition of Asuragen, a Texas-based company focused on genetic carrier screening and oncology testing kits.The deal involved an initial consideration of $215M in cash and
Seekingalpha · 04/06 20:14
Bio-Techne Completes Acquisition of Asuragen for $215 M in Cash Plus Up to $105 M Upon Reaching Milestones >TECH
Bio-Techne Completes Acquisition of Asuragen for $215 M in Cash Plus Up to $105 M Upon Reaching Milestones >TECH
Dow Jones · 04/06 20:09
Bio-Techne Completes Acquisition Of Asuragen, Inc. >TECH
Bio-Techne Completes Acquisition Of Asuragen, Inc. >TECH
Dow Jones · 04/06 20:01
Press Release: Bio-Techne Completes Acquisition of Asuragen, Inc.
Dow Jones · 04/06 20:01
Chromatin Immunoprecipitation Assay Kits Market Share Analysis, Key Growth Drivers, Challenges, Leading Key Players Review, Demand and Upcoming Trend by Forecast to 2026
Apr 06, 2021 (The Expresswire) -- Global "Chromatin Immunoprecipitation Assay Kits Market"(2021-2026) status and position of worldwide and key regions, with...
The Express Wire · 04/06 18:46
Webull provides a variety of real-time TECH stock news. You can receive the latest news about Bio-Techne through multiple platforms. This information may help you make smarter investment decisions.
About TECH
Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences reporting segment supplies specialized proteins, such as cytokines and growth factors, immunoassays, antibodies and reagents, to the biotechnology community. The Protein Sciences segment also provides an array of platforms useful in various areas of protein analysis. The Diagnostics and Genomics reporting segment provides blood chemistry and blood gas quality controls, hematology instrument controls, diagnostics immunoassays and other bulk and custom reagents for the in vitro diagnostic market.